Gastrin Hormone Market Size & Share, by Salt Type (Ammonium Acetate, Trifluoroacetate); Packaging Size (0.5 mg, 1 mg, 5 mg); End-user (Hospital, Specialty Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4036
  • Published Date: Apr 27, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Gastrin Hormone Market size is estimated to reach USD 1.2 Billion by the end of 2035, growing at a CAGR of 5% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of gastrin hormone was over USD 784 Million. The major reason for the global market growth during the forecast period is the rising cases of digestive disorders among the global population. As gastrin hormone stimulates the release of gastric acid, it plays an imperative role in the digestive process which has the ability to break down the proteins in the food that is consumed. Thus, with the rising cases of digestive disorders cases, the need for effective gastrin hormone is raised for bringing the digestion process back to normal. According to data found in a survey, it was found that in 2020, digestive diseases affected almost 60 million to 70 million people, which caused around 4 million hospitalizations, 70 million ambulatory-care visits, and 240,000 deaths in the North American region.

Gastrin hormones are effective medical products that are considered to be high-quality hormones that are produced by the wall of the pyloric end of the stomach in humans. It is highly effective in digestion processes and is responsible for enhancing gastric mucosal growth, gastric motility, and secretion of hydrochloric acid (HCI) into the stomach. The global gastrin hormone market is estimated to foresee tremendous growth owing to the increasing digestion-related diseases, obesity due to improper digestion, and deficiency of gastrin hormone in the body. Furthermore, gut infections along with illnesses occurring in the stomach are other factors that are anticipated to bring favorable opportunities for the expansion of the market during the forecast period.


Gastrin Hormone Market
Get more information on this report: Request Free Sample PDF

Gastrin Hormone Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Cases of Indigestion Among the Global People – People in the world have seen rising cases of indigestion owing to indulgence in a sedentary lifestyle and consumption of junk food and processed eatables. To treat the illness of indigestion, the use of gastrin hormone is highly used by medical professionals. Therefore, the increase in the number of cases of indigestion is expected to escalate the usage of gastrin hormone and subsequently aid in market expansion during the forecast period. For instance, it was suggested that indigestion is a common condition that affects almost 1 in 4 people in the United States each year. Furthermore, it also has been calculated that over 73,000 people in 33 countries are suffering from digestive disorders.
  • Escalation in the Cases of Gastroesophageal Reflux Disease (GERD) - Gastroesophageal reflux disease (GERD) is a medical condition in which the stomach contents leak backward from the stomach into the esophagus (food pipe). This condition is a result of poor diet habits and consumption of highly unhealthy food products with high sodium and processed elements which results in indigestion and further gut-related problems. Thus, the increase in such illnesses is estimated to increase the demand for digestive health products such as gastrin hormones which have the ability to secrete digestive enzymes for proper digestion in human beings. The statistics revealed by the National Library of Medicine stated that in 2019, there were 783.95 million cases of GERD globally. Moreover, it was also calculated that between 1990 and 2019, the total number of prevalent cases, incident cases, and YLDs owing to GERD increased by 77.53%, 74.79%, and 77.19%, respectively.
  • The Surge in the Number of Gut-Conscious People – In the recent period, owing to the number of digestion illnesses and gut-related problems has increased the awareness level of concern about health and fitness. This has increased the number of gut-conscious clients who constantly seek preventive options and use supplements for gut health including prebiotics, food enzymes, and probiotics including gastrin hormones to maintain a strong immune system. It has been suggested that in order to maintain a healthy immune system, nearly 77% of individuals are switching to food including yogurt drinks, and others. Therefore, with more and more people propelling towards maintaining a healthy digestion process, the utilization rate of gastrin hormones is expected to increase which is further anticipated to favor global gastrin hormone market expansion during the forecast period.
  • Burgeoning Geriatric Population with Digestive Issues – The bodies of elderly people tend to become weak and their organs start to deteriorate. As a result, at some times, the food consumed by them is not properly digested which led to gut microbiota and indigestion problems. Therefore, gastrin hormones which aid a smooth digestion process are estimated to create favorable opportunities for market growth during the forecast period. The United Nations estimates that by 2050, 1 in 6 people would be over 65, up from 1 in 11 in 2019.
  • Increasing Desire for Unhealthy Foods – With the fast-paced lives of people, the global population nowadays is more pushed towards the consumption of unhealthy foods owing to their taste and convenience. However, the outcome of eating unhealthy food and processed consumables is the development of diseases and disorders in the body, which in turn, is anticipated to increase the demand for gastrin hormones to restore health and aid in generating opportunities for market growth. For instance, it has been stated that processed food makes up approximately 70% of the U.S. diet, with Americans spending around 10% of their disposable income on fast food. It has also been revealed that one in four Americans eat fast food every day.

 

Challenges

  • Higher Cost of Digestive Hormones – Digestive hormones such as gastrin hormones are manufactured using a lot of rare ingredients which increases the cost of the product. Furthermore, the processing, distribution, storage, and other processes also add additional expenses which subsequently increase the final cost of gastrin hormone. As a result, the adoption rate of gastrin hormones among the population with low and middle income ultimately hamper the growth of the global gastrin hormone market during the forecast period.
  • Complex & changing product requirements
  • Strict Rules to be Followed Before the Launch of New Products

Gastrin Hormone Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~5%

Base Year Market Size (2022)

~ USD 784 Million

Forecast Year Market Size (2035)

~ USD 1254 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

 

Get more information on this report: Request Free Sample PDF

Gastrin Hormone Segmentation

The global gastrin hormone market is segmented and analyzed for demand and supply by salt type into segmented into ammonium acetate, trifluoroacetate, and others. Out of the three types of salt, the ammonium acetate segment is estimated to gain the largest market share of about ~45% in the year 2035. The main use of ammonium acetate is in the form of a food acidity regulator. It is used in the form of a food acidity regulator. In other words, ammonium acetate is a food additive that is useful for changing and controlling the alkalinity or acidity of foods. Thus, the rising cases of acidity are expected to create favorable opportunities for segment expansion in the upcoming years. A recent report published in 2022 stated that about 30% of Indian adults suffer from acidity and indigestion problems. In addition, ammonium acetate improves the production of gastrin hormone that aids the digestion of food and is beneficial in treating gastrointestinal diseases. These factors are projected to maintain the growth of the segment during the assessment period.

The global gastrin hormone market is also segmented and analyzed for demand and supply by end-user into hospitals, specialty clinics, and others. Amongst these segments, the hospital segment is expected to garner a significant share of around ~46% in the year 2035. The major factor for segment growth during the forecast period is the increasing patient footfall in hospitals owing to the rising cases of obesity, ulcers, and infections related to the stomach and gut. A report published in 2020 stated that 1 in 3 adults was overweight and 2 in 5 adults have obesity which is equivalent to 13% of adults being obese and 39% of people being overweight across the globe. Moreover, the availability of better medication and the presence of trained gastroenterologists in the hospitals are also considered to positively contribute to segment growth.

Our in-depth analysis of the global market includes the following segments:

        By Salt Type

  • Ammonium Acetate
  • Trifluoroacetate
  • Others

        By Packaging Size

  • 0.5 mg
  • 1 mg
  • 5 mg
  • Others

        By End User

  • Hospital
  • Specialty Clinics
  • Others
 

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Gastrin Hormone Industry - Regional Synopsis

North American Market Forecast

The market share of gastrin hormone in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~35% by the end of 2035, period on the back of better reimbursement policies, and growing healthcare expenditure in the region. As a result of growing disposable income, the spending capacity on health and medicines has also increased which is subsequently forecasted to increase the utilization rate of gastrin hormone during the analysis period. As per the data from the Centers for Medicare & Medicaid Services, national health expenditure in the U.S. increased to USD 4.1 trillion in 2020, which was USD 12,530 per person. The increasing technological advancement to build products in the probiotics and prebiotic space along with the presence of the world’s strongest healthcare facility is another factor that is estimated to bring favorable opportunities for market growth.

APAC Market Statistics

The Asia Pacific gastrin hormone industry is estimated to be the second largest, registering a share of about ~24% by the end of 2035. The growth of the market can be attributed majorly to the growing existence of giant pharmaceutical manufacturers as well as increasing R&D in the field of biopharmaceuticals. In addition to the other factors, the burgeoning geriatric population along with the large pool of patients and the rising awareness about health and awareness is expected to create a positive outlook for market growth.

Europe Market Forecast

Further, the market in the European region, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The availability of supportive policies by the regulatory bodies that promote the market players to opt for various types of supplements and nutritional additives over a large target population and the region's expanding healthcare industry and rising healthcare expenditure are also anticipated to boost market growth during the forecast period.

Research Nester
Gastrin Hormone Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Global Gastrin Hormone Landscape

top-features-companies
    • Merck KGaA
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • RayBiotech Life, Inc.
    • KareBay Biochem, Inc.
    • Cayman Chemical Company
    • Cambridge Bioscience Limited
    • CPC Scientific Inc.
    • Abcepta
    • GenScript Biotech Corporation
    • Qingdao Echemi Technology Co., Ltd.
    • VWR International, LLC

In the News

  • Nordic BioSite Group (NBG) to acquire UK-based distributor Cambridge Bioscience and Research Donors, a biospecimens company, to reach the European customer base.
  • Cayman Chemical to partner up with Nano Imaging Services and T&T Scientific, to offer multidisciplinary lipid-based drug delivery nanoparticles.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4036
  • Published Date: Apr 27, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing prevalence of gastric diseases, such as gastritis, is estimated to boost the market growth.

The market size of gastrin hormone is anticipated to attain a CAGR OF 5% over the forecast period, i.e., 2023-2035.

Side effects associated with over secretion of gastric acid along with the less awareness level about gastric diseases are some of the factors that are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are RayBiotech Life, Inc., KareBay Biochem, Inc., Cayman Chemical Company, Cambridge Bioscience Limited, CPC Scientific Inc., Abcepta, GenScript Biotech Corporation, Qingdao Echemi Technology Co., Ltd., VWR International, LLC., and other key players.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by salt type, packaging size, end-user, and by region.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Gastrin Hormone Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying